Core Viewpoint - Recent rumors regarding the depletion of personal medical insurance accounts and its impact on reimbursement have been clarified by health insurance departments in various regions, stating that the balance of personal accounts does not affect the reimbursement benefits provided by the pooled fund [2][12]. Group 1: Understanding the Two Funds - The rumors stem from a misunderstanding of the two components of employee medical insurance: the pooled fund and the personal account [14]. - The pooled fund serves as a "public pool" for medical reimbursements, funded by contributions from all insured individuals, covering ordinary outpatient services, chronic disease treatments, and hospitalization costs, with strict reimbursement ratios [15][17]. - The personal account functions as a "personal wallet" for out-of-pocket expenses, such as purchasing medications at designated pharmacies and covering personal costs after reimbursement [4][17]. Group 2: Policy Upgrades - In January of this year, the National Healthcare Security Administration and the Ministry of Finance announced an upgrade to the personal account system, expanding the scope of inter-provincial mutual assistance, breaking geographical restrictions, and enhancing family support functions [6][18]. - This policy upgrade is expected to benefit more individuals and significantly reduce the medical burden on insured persons [7][18]. Group 3: Common Misconceptions and Official Actions - The applicable beneficiaries of the inter-provincial mutual assistance include close relatives of the insured, such as spouses, parents, children, and grandparents [18]. - The funds from personal accounts can be used for personal medical expenses incurred by close relatives, including costs at designated medical institutions and pharmacies [9][18]. - The Central Cyberspace Administration, in collaboration with the National Healthcare Security Administration, is actively combating misinformation related to medical insurance, focusing on three main types of violations: fabricating false information, inciting public anxiety, and misleading the public by associating non-collective procurement products with collective procurement [20].

Core Viewpoint - The National Healthcare Security Administration (NHSA) has released a list of key tasks for the healthcare sector for 2026, emphasizing the opening of cross-province mutual aid for employee medical insurance personal accounts across all provinces [1][3]. Group 1: Cross-Province Mutual Aid - All provinces will open cross-province mutual aid for employee medical insurance personal accounts, allowing funds to cover medical expenses for the insured's close relatives [1][3]. - As of early January 2026, 337 coordinated areas have launched healthcare wallets to facilitate cross-province mutual aid [1][3]. Group 2: Key Tasks for 2026 - By the end of 2026, 80% of designated medical institutions nationwide are expected to achieve instant settlement [4][6]. - At least one batch of national organized drug and high-value medical consumables centralized procurement will be conducted [4][6]. - The direct settlement of maternity medical expenses for inpatient childbirth across coordinated areas within the province will be basically realized [4][6]. Group 3: Additional Services - Maternity allowances will be directly issued to individuals without needing to go through employers, enhancing the efficiency and satisfaction of insured individuals [2][6]. - Key hospitals will enable cross-province retrieval of medical imaging under the healthcare insurance system, with at least 45% of imaging indexes uploaded to the national healthcare information platform by the end of 2026 [3][7].

北京商报讯（记者 胡永新）2月6日，北京商报记者了解到，近期，中央网信办会同国家医保局深入整 治涉医药集中带量采购的网上虚假不实信息，依法依约处置一批污名集采、制造焦虑、误导公众的账 号。根据通报的典型案例，微博账号"成都XXX"，抖音账号"琼波XX""亮晶晶的XX"等，歪曲国家政 策，编造"进口药集体退出中国"等不实信息，煽动网民对原研药与仿制药的对立情绪，其中部分账号旨 在制造公众用药焦虑，引导公众购买相关保健品、高端医疗保险，或诱导公众到特定的互联网平台购 药。涉及的账号已被依法依约采取处置措施。 ...

Core Viewpoint - The Central Cyberspace Administration of China, in collaboration with the National Healthcare Security Administration, is actively addressing false and misleading information related to centralized drug procurement, taking legal actions against accounts that spread anxiety and misinformation [1] Group 1: False Information and Misinformation - Accounts have been identified that fabricate false information regarding the quality of drugs and medical supplies involved in centralized procurement, aiming to attract traffic [1] - Some accounts distort national policies and create false narratives to incite public anxiety regarding original and generic drugs, leading to the promotion of health products and high-end medical insurance [1] - There are instances where non-procurement products are deliberately associated with procurement to mislead the public, damaging the credibility of the procurement process [1]

2月5日，南都N视频记者从"网信中国"公众号获悉，近期，中央网信办会同国家医保局，深入整治涉医 药集中带量采购的网上虚假不实信息，依法依约处置一批污名集采、制造焦虑、误导公众的账号。 据"网信中国"通报的部分典型案例，"心血管XXX主任""护帮X学长""药圈XX""财可XXX"等账号，为吸 引流量，编造集采药品、耗材质量不好的虚假信息，或将网络上搜集到的有关集采视频二次加工后发 布，污名集采政策。涉及的账号已被依法依约采取处置措施。 此外，有账号试图煽动社会情绪，制造公众焦虑。其中，"成都XXX""琼波XX""亮晶晶的XX"等账号， 歪曲国家政策，编造"进口药集体退出中国"等不实信息，煽动网民对原研药与仿制药的对立情绪，其中 部分账号旨在制造公众用药焦虑，引导公众购买相关保健品、高端医疗保险，或诱导公众到特定的互联 网平台购药。目前，涉及的账号已被依法依约采取处置措施。 南都记者留意到，还有账号将非集采产品刻意与集采关联，误导公众。其中，"麻辣XXX""用笔在乐谱 XX""Handsome骨匠XX""biu阿X""边山半XX""小土亘XX"等账号，为了吸引粉丝眼球、蹭集采流量， 发帖称医用手套、输液袋、留置针 ...

近期，中央网信办会同国家医保局深入整治涉医药集中带量采购的网上虚假不实信息，依法依约处置一批污名 集采、制造焦虑、误导公众的账号。现将部分典型案例通报如下。 1.编造虚假信息，污名集采政策，博取流量。小红书账号"心血管XXX主任""护帮X学长"，抖音账号"药圈 XX""财可XXX"等，为吸引流量，编造集采药品、耗材质量不好的虚假信息，或将网络上搜集到的有关集采视 频二次加工后发布，污名集采政策。涉及的账号已被依法依约采取处置措施。 2.煽动社会情绪，制造公众焦虑。微博账号"成都XXX"，抖音账号"琼波XX""亮晶晶的XX"等，歪曲国家政 策，编造"进口药集体退出中国"等不实信息，煽动网民对原研药与仿制药的对立情绪，其中部分账号旨在制造 公众用药焦虑，引导公众购买相关保健品、高端医疗保险，或诱导公众到特定的互联网平台购药。涉及的账号 已被依法依约采取处置措施。 3.将非集采产品刻意与集采关联，误导公众。抖音账号"麻辣XXX""用笔在乐谱XX"，小红书账号"Handsome骨 匠XX""biu阿X"，微博账号"边山半XX""小土亘XX"等，为了吸引粉丝眼球、蹭集采流量，发帖称医用手套、 输液袋、留置针等部分医疗器 ...

2.煽动社会情绪，制造公众焦虑 微博账号"成都XXX"，抖音账号"琼波XX""亮晶晶的XX"等，歪曲国家政策，编造"进口药集体退出中 国"等不实信息，煽动网民对原研药与仿制药的对立情绪，其中部分账号旨在制造公众用药焦虑，引导 公众购买相关保健品、高端医疗保险，或诱导公众到特定的互联网平台购药。涉及的账号已被依法依约 采取处置措施。 3.将非集采产品刻意与集采关联，误导公众 抖音账号"麻辣XXX""用笔在乐谱XX"，小红书账号"Handsome骨匠XX""biu阿X"，微博账号"边山半 XX""小土亘XX"等，为了吸引粉丝眼球、蹭集采流量，发帖称医用手套、输液袋、留置针等部分医疗 器械质量差，实际反映的产品并非集采产品，破坏集采公信力。涉及的账号已被依法依约采取处置措 施。 转自：扬子晚报 据"网信中国"微信公众号2月5日消息，近期，中央网信办会同国家医保局深入整治涉医药集中带量采购 的网上虚假不实信息，依法依约处置一批污名集采、制造焦虑、误导公众的账号。现将部分典型案例通 报如下。 1.编造虚假信息，污名集采政策，博取流量 小红书账号"心血管XXX主任""护帮X学长"，抖音账号"药圈XX""财可XXX"等，为 ...

污名集采、制造焦虑！中央网信办、国家医保局处置一批账号 中新网2月5日电 据"网信中国"微信公众号消息，近期，中央网信办会同国家医保局深入整治涉医药集 中带量采购的网上虚假不实信息，依法依约处置一批污名集采、制造焦虑、误导公众的账号。现将部分 典型案例通报如下。 编辑：张澍楠 广告等商务合作，请点击这里 本文为转载内容，授权事宜请联系原著作权人 中新经纬版权所有，未经书面授权，任何单位及个人不得转载、摘编或以其它方式使用。 关注中新经纬微信公众号(微信搜索"中新经纬"或"jwview")，看更多精彩财经资讯。 1.编造虚假信息，污名集采政策，博取流量。小红书账号"心血管XXX主任""护帮X学长"，抖音账号"药 圈XX""财可XXX"等，为吸引流量，编造集采药品、耗材质量不好的虚假信息，或将网络上搜集到的有 关集采视频二次加工后发布，污名集采政策。涉及的账号已被依法依约采取处置措施。 2.煽动社会情绪，制造公众焦虑。微博账号"成都XXX"，抖音账号"琼波XX""亮晶晶的XX"等，歪曲国 家政策，编造"进口药集体退出中国"等不实信息，煽动网民对原研药与仿制药的对立情绪，其中部分账 号旨在制造公众用药焦虑，引导公众 ...

Core Viewpoint - The announcement by the National Organization for High-Value Medical Consumables Joint Procurement Office initiates a centralized bulk procurement process for drug-coated balloons and urological intervention medical consumables, aiming to standardize and institutionalize the procurement process across the country [1] Group 1: Procurement Process - The centralized bulk procurement is guided by the National Healthcare Security Administration and eight other departments, emphasizing the need for a systematic and regular approach to medical consumables procurement [1] - Representatives from various provinces will form a joint procurement office to represent public medical institutions and participating social medical institutions in the procurement process [1] Group 2: Implementation - The Tianjin Medical Procurement Center is designated to handle the daily operations and specific implementation of the procurement process [1]

Core Viewpoint - The company maintains a stable credit rating outlook while facing challenges such as declining revenue and net profit due to changes in downstream industry policies and market fluctuations [3][5][6]. Company Overview - The company, Baotou Dongbao Biotechnology Co., Ltd., has acquired full ownership of Qingdao Yiqing Biotechnology Co., Ltd., enhancing its vertical integration in the gelatin and hollow capsule industries [3][5]. - The company specializes in the research, production, and sales of gelatin, collagen, hollow capsules, and related products, with a focus on expanding its market presence [5][20]. Financial Performance - For 2024, the company reported total assets of 25.92 billion, total liabilities of 6.26 billion, operating income of 1.88 billion, and net profit of 0.19 billion [3][4]. - The company's revenue and net profit have shown a year-on-year decline due to price reductions in gelatin products and inventory destocking by customers [5][16]. - The operating cash flow remains positive, indicating a stable cash position despite the revenue decline [24]. Industry Environment - The gelatin and collagen industries are experiencing increased regulatory scrutiny, leading to market consolidation and heightened competition among manufacturers [11][12]. - The hollow capsule market is closely tied to the pharmaceutical industry, with growing demand driven by increased health awareness and changing medication habits among consumers [14][15]. Production and Capacity - The company has a gelatin production capacity of 13,500 tons per year, with a utilization rate of 72.07% in 2024, reflecting a decrease from the previous year [16][17]. - The hollow capsule production capacity has increased to 360 billion capsules per year, with a production volume of 304.42 billion capsules in 2024 [21][22]. Risks and Challenges - The company faces risks related to the realization of returns from ongoing projects and the potential for underutilization of production capacity [6][23]. - High equity pledge rates among major shareholders pose a risk of forced liquidation, which could impact the company's financial stability [7][20].